Manuscripts from 2010
Chart Rounds in the Digital Age: A Survey of North American Institutions, M. A. Whiton, A. P. Dicker, E. J. Wuthrick, L. Doyle, A. S. Harrison, and Y. R. Lawrence
MEPE/OF45 as a new target for sensitizing human tumour cells to DNA damage inducers., P Zhang, H Wang, P S N Rowe, B Hu, and Y Wang
Manuscripts from 2009
IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119., Gary A Ezzell; Jay W Burmeister; Nesrin Dogan; Thomas J LoSasso; James G Mechalakos; Dimitris Mihailidis; Andrea Molineu; Jatinder R Palta; Chester R Ramsey; Bill J Salter; Jie Shi; Ping Xia; Ning J Yue; and Ying Xiao, PhD
MEPE/OF45 protects cells from DNA damage induced killing via stabilizing CHK1., Shuang Liu, Hongyan Wang, Xiang Wang, Lin Lu, Ning Gao, Peter S N Rowe, Baocheng Hu, and Ya Wang
Recent trends in soft-tissue infection imaging., Nicholas Petruzzi, MD; Nylla Shanthly, MBBS, DRM; and Mathew L. Thakur, PhD
Aggressive Trimodality Therapy for T1N2M1 Nonsmall Cell Lung Cancer with Synchronous Solitary Brain Metastasis: Case Report and Rationale., Timothy Showalter and Alexander Lin
Genomic biomarkers for molecular imaging: predicting the future., Mathew L. Thakur
Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model., Phyllis Wachsberger, Randy Burd, Anderson Ryan, Constantine Daskalakis, and Adam P. Dicker
Initial Tumor Metabolic Parameters (Maximum SUV and Metabolic Volume) Predict Death From Lung Cancer and Rapid SUV Decline is Associated with Local Control, Maria Werner-Wasik, Edward Pequignot, Terry Hyslop, Brian Shulli, Ying Xiao, Mitchell Machtay, Amy Taylor, Walter Curran, and Rita Axelrod
In Reply to Dr. Hurkmans et al., Ying Xiao, PhD; Lech S. Papiez, PhD; and James M. Galvin, DSc
Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer., Ying Xiao, Lech Papiez, Rebecca Paulus, Robert Timmerman, William L. Straube, Walter R. Bosch, Jeff Michalski, and James M. Galvin
A real-time prostate cancer detection technique using needle insertion force and patient-specific criteria during percutaneous intervention, Kaiguo Yan, T. Podder, L. Li, J. Joseph, D. R. Rubens, E. M. Messing, L. Liao, and Y. Yu
Manuscripts from 2008
Distinguishing post-treatment changes from recurrent disease in cholangiocarcinoma: a case report., Timothy N Showalter, A Omer Nawaz, Frederick M Fellin, Pramila R Anne, Ernest L Rosato, and Adam P Dicker
Increasing tumor volume is predictive of poor overall and progression-free survival: Secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer, Maria Werner-Wasik, R. Suzanne Swann, Jeffrey Bradley, Mary Graham, Bahman Emami, James Purdy, and William Sause
Radioactive seed immobilization techniques for interstitial brachytherapy, K. Yan, T. Podder, I. Buzurovic, Y. Hu, E. Messing, D. Rubens, A. Dicker, R. Valicenti, N. Sarkar, W. Ng, and Y. Yu
Manuscripts from 2007
Robot-Assisted Prostate Brachytherapy, Yan Yu, Tarun Podder, Y D. Zhang, W S. Ng, V Misic, J Sherman, L Fu, D Fuller, D J. Rubens, J D. Strang, R A. Brasacchio, and E M. Messing
Manuscripts from 2006
Foreword: Anti-angiogenic therapy: Maximizing therapeutic gain, Adam P. Dicker
A phase II study of acute toxicity for Celebrex(TM) (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: Primary endpoint analysis of RTOG 0128, David K. Gaffney, Kathryn Winter, Adam P. Dicker, Brigitte Miller, Patricia J. Eifel, Janice Ryu, Vilija Avizonis, Mitch Fromm, and Kathryn Greven
Antisense inhibition of cyclin D1 expression is equivalent to flavopiridol for radiosensitization of zebrafish embryos, Mary Frances McAleer, Kevin T. Duffy, William R. Davidson, Gabor Kari, Adam P. Dicker, Ulrich Rodeck, and Eric Wickstrom
The effect of Hus1 on ionizing radiation sensitivity is associated with homologous recombination repair but is independent of non-homologous end-joining, Robert S. Weiss, Xiang Wang, Baocheng Hu, and Ya Wang
Manuscripts from 2001
Department of Radiation Oncology and Kimmel Cancer Center, Thomas jefferson University, The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia., Anna Marsh, Amanda B Spurdle, Bruce C Turner, Sian Fereday, Heather Thorne, Gulietta M Pupo, Graham J Mann, John L Hopper, Joseph F Sambrook, and Georgia Chenevix-Trench
Cellular Senescence: Ex Vivo p53-Dependent Asymmetric Cell Kinetics., Lakshmi Rambhatla, Shirley A. Bohn, Patrizia B. Stadler, Jonathan T. Boyd, Ronald A. Coss, and James L. Sherley
